Magnesium Sulfate 50% Inj, 10ml
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. It's essential to follow the dosage instructions carefully. This medication can be administered in two ways: as an injection into a muscle or as an infusion into a vein over a specified period.
Storing and Disposing of Your Medication
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the best storage method.
Missing a Dose
If you miss a dose, contact your doctor to receive guidance on what to do next.
Lifestyle & Tips
- Report any unusual symptoms immediately to your healthcare provider.
- Do not take other medications or supplements without consulting your doctor, especially antacids or laxatives containing magnesium.
Available Forms & Alternatives
Available Strengths:
- Magnesium Oxide 400mg Tablets
- Magnesium Sulfate 50% Inj, 10ml
- Magnesium 500mg Tablets
- Magnesium Sulfate 40mg/ml Inj, 50ml
- Magnesium Chloride 20% Inj, 50ml
- Magnesium Sulf 40mg/ml Inj, 100ml
- Magnesium Sulfate 50% Inj, 50ml
- Magnesium 200mg Tablets
- Magnesium Sulfate 50% Inj, 2ml
- Magnesium 300mg Capsules
- Magnesium Sulfate 40mg/ml Inj, 50ml
- Magnesium Sulfate 80mg/ml Inj, 50ml
- Magnesium 250mg Tablets
- Magnesium Sulfate 80mg/ml Inj
- Magn Sulf/d5w 10mg/ml Inj, 100ml
- Magnesium Oxide 250mg Tablets
- Magnesium Citrate Soln Lemon 296ml
- Magnesium Sulfate 50% Inj, 20ml
- Magnesium Su 40g/1000ml Inj, 1000ml
- Magnesium Sulfate 20gm/500ml Inj
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high magnesium levels, including:
+ Confusion
+ Feeling sluggish
+ Slow movements
+ Shortness of breath
+ Upset stomach
+ Severe dizziness or passing out
Signs of low calcium levels, such as:
+ Muscle cramps or spasms
+ Numbness and tingling
+ Seizures
Other severe side effects, including:
+ Slow heartbeat
+ Flushing
+ Inability to move
+ Changes in eyesight
+ Feeling cold
+ Excessive sweating
If you experience any of the following symptoms, seek medical help immediately, as they could be signs of a life-threatening muscle problem:
New or worsening muscle weakness
Trouble chewing or swallowing
Trouble breathing
Droopy eyelids
* Changes in eyesight, such as blurred vision or double vision
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to contact your doctor or seek medical help if you notice any side effects that bother you or do not go away.
Not all possible side effects are listed here. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Feeling very tired or drowsy
- Muscle weakness
- Difficulty breathing or slow breathing
- Feeling dizzy or lightheaded
- Flushing or sweating
- Slow heartbeat
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have a heart block or any pre-existing heart problems.
* If you are currently taking nifedipine or terbutaline, as these medications may interact with this drug.
Please note that this is not an exhaustive list of all potential interactions. To ensure your safety, it is crucial to disclose all of your medications, including prescription and over-the-counter drugs, natural products, and vitamins, as well as any health problems you may have. Your doctor and pharmacist need this information to determine whether it is safe for you to take this medication in conjunction with your other treatments.
Remember, do not start, stop, or adjust the dosage of any medication without first consulting your doctor to confirm that it is safe to do so.
Precautions & Cautions
Regular blood tests are crucial while taking this medication, as directed by your doctor. It is also important to discuss your test results with your doctor.
This medication may contain aluminum, which can lead to aluminum toxicity with long-term use. The risk of aluminum toxicity is higher in individuals with kidney problems and premature infants. Therefore, it is crucial to discuss this risk with your doctor.
If you have myasthenia gravis, do not take this medication, as it can cause severe and potentially life-threatening breathing problems.
Women who are pregnant or become pregnant while taking this medication should contact their doctor immediately, as it may harm the unborn baby.
If you are breast-feeding, inform your doctor, as you will need to discuss the potential risks to your baby and determine the best course of action.
Overdose Information
Overdose Symptoms:
- Extreme drowsiness
- Loss of reflexes (e.g., knee jerk)
- Severe muscle weakness
- Very slow or shallow breathing
- Low blood pressure
- Slow heart rate
- Coma
- Cardiac arrest
What to Do:
Immediate medical attention is required. The antidote is intravenous calcium gluconate. Call 911 or Poison Control (1-800-222-1222) immediately.
Drug Interactions
Major Interactions
- Neuromuscular blocking agents (e.g., rocuronium, vecuronium): Potentiates and prolongs neuromuscular blockade, leading to increased risk of respiratory depression/paralysis.
- Calcium channel blockers (e.g., nifedipine, amlodipine): Increased risk of hypotension and bradycardia due to additive vasodilatory and myocardial depressant effects.
- CNS depressants (e.g., opioids, benzodiazepines, barbiturates, general anesthetics): Additive CNS depression, leading to increased sedation and respiratory depression.
Moderate Interactions
- Digoxin: Magnesium sulfate can increase the risk of digoxin toxicity in patients with hypokalemia or hypomagnesemia, or if given rapidly IV.
- Diuretics (loop and thiazide): May increase renal excretion of magnesium, potentially leading to hypomagnesemia (though magnesium sulfate is given to treat hypomagnesemia, this interaction is relevant for chronic use of diuretics).
- Aminoglycosides: May potentiate neuromuscular blockade.
Minor Interactions
- Tetracyclines/Quinolones (oral): Magnesium can chelate these antibiotics, reducing their absorption (not relevant for IV magnesium sulfate).
Monitoring
Baseline Monitoring
Rationale: To establish baseline and guide initial dosing, especially in hypomagnesemia.
Timing: Prior to initiation of therapy.
Rationale: Magnesium is renally excreted; impaired renal function increases risk of toxicity.
Timing: Prior to initiation of therapy.
Rationale: Baseline assessment for comparison, as loss of DTRs is an early sign of hypermagnesemia.
Timing: Prior to initiation of therapy.
Rationale: Baseline assessment for comparison, as hypotension and respiratory depression are signs of toxicity.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: Every 4-6 hours during continuous infusion, or as clinically indicated.
Target: 4-7 mg/dL (for pre-eclampsia/eclampsia); 1.5-2.5 mg/dL (for hypomagnesemia correction)
Action Threshold: >7 mg/dL (loss of DTRs), >10 mg/dL (respiratory depression), >12 mg/dL (cardiac arrest); hold dose and consider calcium gluconate.
Frequency: Hourly during continuous infusion.
Target: Present (2+)
Action Threshold: Absent DTRs (0); hold dose and assess for other signs of toxicity.
Frequency: Hourly during continuous infusion.
Target: >12 breaths/min
Action Threshold: <12 breaths/min; hold dose and assess for other signs of toxicity, consider respiratory support.
Frequency: Hourly during continuous infusion.
Target: >25-30 mL/hour or >100 mL/4 hours
Action Threshold: <25 mL/hour; indicates impaired renal excretion and increased risk of toxicity.
Frequency: Hourly during continuous infusion.
Target: Individualized based on indication
Action Threshold: Significant hypotension; hold dose and assess.
Symptom Monitoring
- Lethargy
- Drowsiness
- Muscle weakness
- Flushing
- Sweating
- Hypotension
- Bradycardia
- Absent deep tendon reflexes
- Respiratory depression
- Cardiac arrest
Special Patient Groups
Pregnancy
Category D. While associated with fetal abnormalities (e.g., hypocalcemia, skeletal abnormalities) with prolonged use (more than 5-7 days) during pregnancy, it is considered the drug of choice for the prevention and treatment of seizures in severe pre-eclampsia and eclampsia due to its life-saving benefits for the mother. Short-term use for these indications is generally considered safe and effective.
Trimester-Specific Risks:
Lactation
Magnesium is a natural component of breast milk. While magnesium sulfate is excreted into breast milk, the amount is generally considered low and unlikely to cause adverse effects in a healthy, full-term infant. Monitor infant for signs of diarrhea or sedation. L3 (Moderately safe).
Pediatric Use
Used for hypomagnesemia, severe acute asthma, and certain cardiac arrhythmias (e.g., Torsades de Pointes). Dosing is weight-based and requires careful monitoring of serum magnesium levels, vital signs, and DTRs due to risk of toxicity.
Geriatric Use
Elderly patients are more likely to have impaired renal function, which increases the risk of magnesium toxicity. Lower doses and more frequent monitoring of serum magnesium, renal function, and clinical signs of toxicity are recommended.
Clinical Information
Clinical Pearls
- Always have calcium gluconate (10% solution, 10 mL IV over 3 minutes) readily available as an antidote for magnesium toxicity.
- Administer IV magnesium sulfate slowly to avoid hypotension, flushing, and cardiac arrest.
- Monitor urine output closely; oliguria significantly increases the risk of magnesium toxicity.
- Assess deep tendon reflexes (DTRs) frequently; loss of DTRs is an early sign of hypermagnesemia.
- Respiratory rate should be monitored hourly; respiratory depression is a serious complication of hypermagnesemia.
- Magnesium sulfate is contraindicated in patients with myocardial damage or heart block.
- For pre-eclampsia/eclampsia, continue magnesium sulfate for at least 24 hours postpartum or until the patient is stable and seizure-free.
Alternative Therapies
- For eclampsia/pre-eclampsia: Antihypertensives (e.g., labetalol, hydralazine) for blood pressure control; other anticonvulsants (e.g., phenytoin, benzodiazepines) are less preferred for eclampsia.
- For hypomagnesemia: Oral magnesium supplements (for mild cases).
- For asthma: Beta-agonists, corticosteroids, anticholinergics.
- For Torsades de Pointes: Electrical cardioversion, isoproterenol, overdrive pacing.